Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourBearish
15 minLeaning Bullish
5 minConsolidating
Daily trend turns down below $353.69
Key levels
Resistance$488.89
Resistance$456.50
Support$434.13
Support$399.35
Latest news & SEC filings
SEC FilingHumana Inc filed an insider trading report (Form 4)
NewsHumana insider sells company stock
AnalystWells Fargo keeps Overweight rating on Humana, lifts target to $602
All HUM news →Humana is a health insurer and healthcare services company based in Louisville, Kentucky. It offers Medicare Advantage plans, stand-alone prescription drug coverage, Medicaid and military health programs, plus specialty benefits like dental and vision. Its CenterWell segment provides pharmacy, primary care, and home health services. It serves Medicare and Medicaid participants, military personnel, employers, and individuals across the United States.
Based on the company's 10-K filed Feb 19, 2026.
NYSE · Healthcare
SEPT Low Target
$370.00
SEPT Mid Target
$505.00
SEPT High Target
$602.00
Analyst Consensus
$505.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HUM.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$430.58
22
Moat Score
NONE
6/9
Piotroski Score
5.1
Altman Z-Score
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
BUYING
8 buys / 7 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Smith Paul John | director | Buy | 544 | - | Aug 1, 2026 |
| Crawford Frederick John | director | Buy | 544 | - | Aug 1, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
10.1%
3yr Revenue CAGR
11.8%
EPS Growth YoY
-1.4%
FCF Growth YoY
-84.3%
Revenue Trend
STABLE
SEPT Investing tracks real-time dark pool institutional trades for HUM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:10:23 | $443.68 | 90,000 | $$39.9M | BUY |
| 21:08:01 | $443.68 | 1,651 | $$733K | BUY |
| 21:03:44 | $443.68 | 52,307 | $$23.2M | BUY |
| 21:03:34 | $443.68 | 6,636 | $$2.9M | BUY |
| 21:03:34 | $443.68 | 1,124 | $$499K | BUY |
5 dark pool trades shown · $$67.3M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for HUM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $440 | Dec 18 | 36 | $$10.8K | 5 | SWEEP |
| PUT | $440 | Dec 18 | 36 | $$10.8K | 5 | SWEEP |
| PUT | $440 | Dec 18 | 36 | $$8680 | 4 | SWEEP |
| PUT | $440 | Dec 18 | 36 | $$2170 | 1 | SWEEP |
| PUT | $440 | Dec 18 | 36 | $$2170 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for HUMANA INC (HUM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HUMANA INC (HUM) is at $443.74, down 0.58% (-$2.57) at the Nov 12, 2026 close.
Latest HUM news — Nov 12, 2026: Humana Inc filed an insider trading report (Form 4) · Nov 12, 2026: Humana insider sells company stock
Humana shares jumped 4.33% to close at $432.98 after the health insurer reported a quarterly loss that was narrower than analysts expected and raised its profit outlook for 2026. The stock traded in a wide range on heavy volume of 2.21 million shares, hitting a high of $444.00 before settling.
The average analyst price target for HUM is $505.00, ranging from $370 to $602, based on 16 analysts. Latest: Wells Fargo maintains on Nov 12, 2026.
Analyst ratings for HUM: 10 Buy, 40 Hold, 0 Sell — consensus Hold.
HUM last reported on Nov 6, 2026: EPS -$0.70 vs -$1.00 expected — a beat of 30.0%.
HUM trades at a P/E of 43.3 vs a Healthcare average of 17.7.
Yes. HUM's dividend yield is 1.39%.
Support: $434.13, $399.35, $375.86. Resistance: $456.50, $488.89.
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
Nov 12, 2026: Humana Inc filed an insider trading report (Form 4) · Nov 12, 2026: Humana insider sells company stock · Nov 12, 2026: Wells Fargo keeps Overweight rating on Humana, lifts target to $602